Published in

Elsevier, Urologic Oncology: Seminars and Original Investigations, 5(31), p. 671-675

DOI: 10.1016/j.urolonc.2011.03.011

Links

Tools

Export citation

Search in Google Scholar

Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO